Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-039308
Filing Date
2025-08-08
Accepted
2025-08-08 16:43:33
Documents
1
Period of Report
2025-08-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1754685809.html 4  
1 FORM 4 wk-form4_1754685809.xml 4 4781
  Complete submission text file 0001628280-25-039308.txt   6330
Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address
Bhatt Padmanabh P. (Reporting) CIK: 0001539215 (see all company filings)